Mostrando 6 resultados de: 6
Filtros aplicados
Publisher
British Journal of Cancer(1)
Cancer Letters(1)
Genome Biology(1)
Human Mutation(1)
Medicina Oral, Patologia Oral y Cirugia Bucal(1)
BRCA1-2 mutations in breast cancer: Identification of nine new variants of BRCA1-2 genes in a population from central Western Spain
ArticleAbstract: We carried out a mutational analysis of BRCA1 and BRCA2 genes in 103 individuals from a population iPalabras claves:BRCA1, BRCA2, Familial breast cancer, Pathogenic mutations, Silent mutations, Unclassified variantsAutores:Barco E., Cruz-Hernandez J.J., Fonseca E., Gomez-Bernal A., González-Sarmiento R., Portugal T., Raquel Salazar-Lugo, Rodríguez-Sánchez C.A., Sánchez-Valdivieso E.A.Fuentes:scopusAnalysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: A high proportion of mutations unique to Spain and evidence of founder effects
ArticleAbstract: We screened index cases from 410 Spanish breast/ovarian cancer families and 214 patients (19 of themPalabras claves:BRCA1, BRCA2, Breast cancer, hebkp_reditary, Cáncer, SpanishAutores:Alonso C., Armengod M.E., Baiget M., Benitez J., Caldés T., Campos B., Carracedo Á., Cervantes A., Chaves J., Cruz-Hernandez J.J., De la Hoya M., Díaz-Rubio E., Díez O., Durán M., Esteban E., González-Sarmiento R., Martinez-Ferrandis J.I., Miner C., Osorio A., Raquel Salazar-Lugo, Rodríguez-López R., San Román J.M., Torres M., Vega A., Velasco E.Fuentes:scopusE-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma
ArticleAbstract: Objectives: Study the loss or reduction of the cellular adhesion mediated for E-cadherin in oral leuPalabras claves:Collagen IV, E-cadherin, Immunohistochemistry, Laminin, oral cancer, Oral Leucoplasia, Tissue microarraysAutores:Bullón Sopelana A., Cruz-Hernandez J.J., Del Mar Abad M., Fonseca Sánchez E., Gonzalez R.J., Purificación Galindo-Villardón, Santos García A.Fuentes:scopusUnraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach
ArticleAbstract: Background: An essential question in cancer is why individuals with the same disease have differentPalabras claves:Autores:Alonso-López D., Blanco-Gómez A., Bowen B., Castellanos-Martín A., Castillo-Lluva S., Cruz-Hernandez J.J., De Las Rivas J., Del Mar Abad M., García-Cenador M.B., García-Criado J., González-Sarmiento R., Hontecillas-Prieto L., Isidoro-García M., Lee D.Y., Mao J.H., Martín-Seisdedos C., Northen T., Patino-Alonso M.C., Perez-Losada J., Purificación Galindo-Villardón, Reindl W., Rodríguez-Sánchez C.A., Sáez-Freire M.d.M., Villar L.P.D.Fuentes:scopusSalamanca University Hospital experience in the adjuvant systemic treatment of loco-regional breast cancer. Results of a medical assistance protocol of a seven-year follow-up study
ArticleAbstract: Purpose: To evaluate the effectiveness of the adjuvant systemic therapy of breast cancer in terms ofPalabras claves:Adjuvant treatment, Anthracycline, Breast Cancer, chemotherapy, TamoxifenAutores:Cruz-Hernandez J.J., Del Barco Morillo E., Fonseca E., García Mata J., García R., Gomez-Bernal A., López Mateos Y., Martín G., Raquel Salazar-Lugo, Rodríguez-Sánchez C.A., Ruiz Martín M.I., Sanchez P.L.Fuentes:scopusγ-Heregulin has no biological significance in primary breast cancer [1]
OtherAbstract:Palabras claves:Autores:Cruz-Hernandez J.J., Del Mar Abad M., Gómez A., Gómez-Alonso A., González-Sarmiento R., Raquel Salazar-Lugo, Sánchez-Valdivieso E.A.Fuentes:scopus